• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Medline officially launches Mpower™, a digital control tower designed to predict, respond and resolve supply chain risks

    5/4/26 1:12:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care
    Get the next $MDLN alert in real time by email

    First wave of Medline customers begin leveraging Mpower to strengthen supply chain resiliency

    NORTHFIELD, Ill., May 4, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that its cloud-based, AI-powered supply chain technology called Mpower™ is now available to help healthcare providers anticipate and respond to potential disruptions before they impact patient care. Built in collaboration with Microsoft and developed with direct input from health systems across the country, Mpower represents a significant step forward in modernizing healthcare supply chain decision-making.

    Medline's AI-powered supply chain technology called Mpower™ is now available to help healthcare providers anticipate and respond to potential supply chain disruptions before they impact patient care.

    The solution is a digital control tower that predicts future risks, offers real-time solutions with proactive optimizations and automates workflows – bringing Medline's customer supply and demand data, predictive analytics and workflow automation together into an intuitive and actionable dashboard. With real-time insights, Mpower helps providers proactively identify at-risk items earlier and streamline their product substitutions and approval workflows, thereby reducing the daily operational burden for supply chain and clinical teams.

    Mpower also includes an integrated AI chat agent that enables users to ask questions, explore product alternatives and streamline clinical approvals directly within the platform. The system draws on Medline's extensive, end‑to‑end supply chain data as both a manufacturer and distributor to deliver enhanced real-time visibility into inventory positions, demand forecasts and potential vulnerabilities across supply networks. Leveraging the Microsoft Office 365 integration users are familiar with and the advanced data security of Microsoft Azure, Mpower is designed to be straightforward and secure to integrate, with minimal training required and the ability to deploy quickly.

    "Mpower reflects how we approach technology at Medline – building practical solutions in close collaboration with partners and customers," said Marshall Lancaster, Medline chief information officer. "Working with Microsoft, we focused on creating a cloud‑based platform that can be deployed efficiently, integrates seamlessly into existing environments and delivers meaningful value from day one."

    Following an early release with 10 well-known U.S. health systems, all of which worked closely with Medline to test, refine and help shape the platform ahead of broader availability, initial data shows a more than 50% efficiency gain in order substitution workflows and decision making compared to a five- to seven-day baseline without Mpower. Health systems using Mpower along with integrating into Medline's pre-approved AutoSub program saw a 1-2% increase in unadjusted fill-rates.

    "We're appreciative for the years of collaboration with providers who told us they needed better visibility, simpler workflows and smarter tools to help manage an increasingly complex global supply chain," said Marc Phillips, Medline senior vice president, supply chain solutions. "By combining Medline's supply chain expertise with Microsoft's cloud and AI capabilities, we expect the technology to play a central role in helping healthcare providers navigate ongoing volatility while building more resilient, data-driven supply chains for the future."

    Mpower is rolling out to Medline customers in phases throughout 2026, with additional capabilities planned as the platform evolves.

    Learn more about how Medline can support customers in optimizing their supply chains at go.medline.com/mpower.

    About Medline

    Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.

    Unless otherwise indicated, all figures are as of Dec. 31, 2025. 

    Medline Logo (PRNewsfoto/Medline)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medline-officially-launches-mpower-a-digital-control-tower-designed-to-predict-respond-and-resolve-supply-chain-risks-302761607.html

    SOURCE Medline

    Get the next $MDLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDLN

    DatePrice TargetRatingAnalyst
    3/11/2026$60.00Buy
    Citigroup
    2/5/2026$55.00Buy
    Tigress Financial
    1/21/2026$50.00 → $55.00Buy
    BTIG Research
    1/12/2026$48.00Buy
    Citigroup
    1/12/2026$38.00Neutral
    BNP Paribas Exane
    1/12/2026$50.00Overweight
    Analyst
    1/12/2026$50.00Overweight
    Piper Sandler
    1/12/2026$48.00Overweight
    Morgan Stanley
    More analyst ratings

    $MDLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on Medline with a new price target

    Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00

    3/11/26 8:38:58 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Tigress Financial initiated coverage on Medline with a new price target

    Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00

    2/5/26 10:03:24 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    BTIG Research reiterated coverage on Medline with a new price target

    BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously

    1/21/26 1:17:48 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 6:16:21 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 6:05:43 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 4:15:05 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    SEC Filings

    View All

    Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement

    8-K - Medline Inc. (0002046386) (Filer)

    6/2/26 8:06:32 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form 424B4 filed by Medline Inc.

    424B4 - Medline Inc. (0002046386) (Filer)

    5/26/26 4:05:33 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Medline Inc.

    EFFECT - Medline Inc. (0002046386) (Filer)

    5/22/26 12:15:23 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 5:26:57 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Andrew J. was granted 30,655 units of Class B Common Stock and bought $74,999,974 worth of shares (2,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:06 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Charles N. was granted 64,005 units of Class B Common Stock and bought $74,799,990 worth of shares (2,579,310 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:04 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medline's Prime Vendor model expands outside the United States

    Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement is with Mohawk Medbuy (MMC), one of Canada's largest healthcare procurement organizations, to support warehouse and supply chain logistics for its hospitals in Southwestern Ontario and builds from best practices from similar agreements with hundreds of healthcare providers in the U.S.

    5/29/26 10:25:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Inc. announces closing of upsized secondary offering of Class A common stock

    NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei

    5/28/26 4:30:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline announces participation in upcoming investor conferences

    NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET. Webcasts of the presentations will be a

    5/27/26 7:30:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Financials

    Live finance-specific insights

    View All

    MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

    EscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut

    5/27/26 7:00:00 AM ET
    $MDLN
    $MDWD
    Medical/Dental Instruments
    Health Care
    Medicinal Chemicals and Botanical Products

    Medline Reports First Quarter 2026 Results

    Net sales of $7.4 billion, an increase of 10.7%Net income of $239 million, a decrease of 25.8%Adjusted EBITDA1 of $776 million, a decrease of 10.6%Raising full year 2026 Organic Sales2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026. "We started 2026 with strong momentum—growing with our existing customers, executing implementations at scale and winning new customers," said Jim Boyle, chief executive off

    5/6/26 7:30:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline to report first quarter 2026 results on May 6, 2026

    NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the largest pr

    4/8/26 9:00:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care